"Biguanides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
| Descriptor ID |
D001645
|
| MeSH Number(s) |
D02.078.370.141
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biguanides".
Below are MeSH descriptors whose meaning is more specific than "Biguanides".
This graph shows the total number of publications written about "Biguanides" by people in this website by year, and whether "Biguanides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2018 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Biguanides" by people in Profiles.
-
Comparison of the bactericidal effect of cold atmospheric pressure plasma (CAPP), antimicrobial photodynamic therapy (aPDT), and polihexanide (PHX) in a novel wet surface model to mimic oral cavity application. J Craniomaxillofac Surg. 2018 Dec; 46(12):2197-2202.
-
Amebaborne "Attilina massiliensis" Keratitis, France. Emerg Infect Dis. 2018 02; 24(2):387-389.
-
Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide In Vitro and In Vivo. Antimicrob Agents Chemother. 2017 10; 61(10).
-
Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015. PLoS One. 2017; 12(6):e0178764.
-
Understanding the anxiety phenomenology in psychotic prodrome: A case report. Asian J Psychiatr. 2017 Aug; 28:88.